Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 9:31 AM ET

Date/Time Source News Release
05/23/2025 08:29 AM EDT Business Wire Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
05/14/2025 07:35 AM EDT Business Wire Crescita Reports First Quarter 2025 Results
03/18/2025 07:30 AM EDT Business Wire Crescita Reports Q4 and Fiscal 2024 Results
11/06/2024 07:30 AM EST Business Wire Crescita Reports Third Quarter 2024 Results
09/24/2024 05:00 PM EDT Business Wire Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
09/12/2024 07:30 AM EDT Business Wire Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
08/07/2024 07:30 AM EDT Business Wire Crescita Reports Second Quarter 2024 Results
07/22/2024 07:30 AM EDT Business Wire Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
07/19/2024 07:30 AM EDT Business Wire Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
07/17/2024 08:00 AM EDT Business Wire Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device
Page

Additional News

As of June 4, 2025 • 9:31 AM ET

Date/Time Source News Release
05/14/2025 08:42 AM EDT SeekingAlpha Crescita Therapeutics reports Q1 results
03/19/2025 12:57 PM EDT SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.01, revenue of C$6.9M
11/06/2024 10:24 AM EST SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.05, revenue of C$3.59M
08/08/2024 11:24 AM EDT SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.05, revenue of C$4.09M
07/19/2024 07:45 AM EDT SeekingAlpha Leading Canadian healthcare services provider selects Crescita as exclusive manufacturing partner
05/08/2024 10:06 AM EDT SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.03, revenue of C$4.9M
03/14/2024 09:59 AM EDT SeekingAlpha Crescita Therapeutics reports Q4 results
11/08/2023 09:11 AM EST SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03M
08/09/2023 12:45 PM EDT SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.01, revenue of C$5.2M
05/11/2023 01:50 PM EDT SeekingAlpha Crescita Therapeutics GAAP EPS of -C$0.01, revenue of C$4.6M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.